Trial · NCT01116648
Participant flow630
How many started, completed or left each group, period by period.
1 to 20 of 630
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase 1 Dose Level 0 | STARTED | Dose Level 0 (20mg Ced+100mg Olap) | 3 | |
| Phase 1 Dose Level 0 | STARTED | Dose Level 1 (20mg Ced + 200mg Olap) | 0 | |
| Phase 1 Dose Level 0 | STARTED | Dose Level 2 (30mg Ced + 200mg Olap) | 0 | |
| Phase 1 Dose Level 0 | STARTED | Dose Level 3 (30mg Ced + 400mg Olap) | 0 | |
| Phase 1 Dose Level 0 | STARTED | Expansion Cohort at MTD | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 2 - Olaparib Alone | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 2 - Cediranib/Olaparib | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T Dose Level 0-TA | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T Dose Level 1-TA | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T Dose Level 2-TA | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T Dose Level 0-TB | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T Dose Level 1-TB | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T Dose Level 2-TB | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T PKOlap Expansion | 0 | |
| Phase 1 Dose Level 0 | STARTED | Phase 1-T PKCed Expansion | 0 | |
| Phase 1 Dose Level 0 | COMPLETED | Dose Level 0 (20mg Ced+100mg Olap) | 3 | |
| Phase 1 Dose Level 0 | COMPLETED | Dose Level 1 (20mg Ced + 200mg Olap) | 0 | |
| Phase 1 Dose Level 0 | COMPLETED | Dose Level 2 (30mg Ced + 200mg Olap) | 0 | |
| Phase 1 Dose Level 0 | COMPLETED | Dose Level 3 (30mg Ced + 400mg Olap) | 0 | |
| Phase 1 Dose Level 0 | COMPLETED | Expansion Cohort at MTD | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01116648/flow